Market Place
Sourcing Support
All News #Library
Biotech
Silence Therapeutics Reports Q4 and FY2025 Results, Highlights
05 Mar 2026 //
PHARMIWEB
Silence Therapeutics Joins Chat at Jefferies Health Conference
12 Nov 2025 //
BUSINESSWIRE
Silence Therapeutics Completes Enrollment in SANRECO Ph 2 Study
23 Oct 2025 //
BUSINESSWIRE
Silence Highlights Ph1 Divesiran Data for Polycythemia Vera
12 Jun 2025 //
BUSINESSWIRE
Silence Therapeutics Welcomes Tim McInerney to Board of Directors
06 May 2025 //
BUSINESSWIRE
Silence To Webcast At Leerink Partners Healthcare Conference
05 Mar 2025 //
BUSINESSWIRE
Silence slows zerlasiran, as Hansoh leaves $1.3B biobucks collab
28 Feb 2025 //
FIERCE BIOTECH
Silence Therapeutics to Report Q4 & 2024 Results on Feb 27
13 Feb 2025 //
BUSINESSWIRE
Silence Therapeutics to Participate in Piper Sandler Conference
26 Nov 2024 //
BUSINESSWIRE
Silence Therapeutics`s Late-Breaking Zerlasiran Data at AHA 2024
18 Nov 2024 //
BUSINESSWIRE
Silence Therapeutics to Join Fireside Chat at Jefferies London
13 Nov 2024 //
BUSINESSWIRE
Silence Therapeutics Reports Q2 2024 Financial Results And Business Highlights
15 Aug 2024 //
BUSINESSWIRE
Silence breaks phase 1 data on blood disorder prospect
27 Jun 2024 //
FIERCE BIOTECH
Silence Announces JAMA Publication of Zerlasiran
08 Apr 2024 //
BUSINESSWIRE
Silence Therapeutics Achieves $10 MMilestone Payment from AZ Collaboration
04 May 2023 //
BUSINESSWIRE
Silence Therapeutics Earns $10M AZ Milestone in siRNA Alliance
04 May 2023 //
CONTRACT PHARMA
Silence Therapeutics to Buyback siRNA Complement Assets
28 Mar 2023 //
BUSINESSWIRE
Silence takes back 2 complement programs from Mallinckrodt
28 Mar 2023 //
FIERCE BIOTECH
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.